Explore Texture and Colour Enhancement Imaging
One dedicated platform: EVIS X1 merges the two worlds of EVIS EXERA III and EVIS LUCERA ELITE into one —resulting in a vastly extended portfolio of compatible endoscopes.
In AI, we recognise the power of elevating endoscopic imaging to greater levels. Considering ENDO-AID CADe as a first step, we are planning additional AI-powered applications for image detection and characterisation.
EVIS X1 provides diagnostic and therapeutic innovation alongside proven technologies to improve endoscopic procedures and endoscope handling.
Sources related to NBI:
1 Olympus Proven; available at https://www.olympus-proven.com.au/less-biopsies/.
2 Olympus Proven; available at https://www.olympus-proven.com.au/increased-adr/.
3 Thosani et al. Gastrointest Endosc 2016 Apr; 83(4): 684-698.e7.
4 Pimentel-Nunes et al. Endoscopy 2019; 51: 365-388.
5 Yao et al. New Challenges in Gastrointestinal Endoscopy 2008, pp. 169-176.
6 Dayyeh et al. Gastrointest Endosc. 2015 Mar; 81(3): 502.e1-502.e16.
7 Kaminski et al. Endoscopy. 2014 May; 46(5): 435-49.
8 National Institute for Health and Care Excellence (NICE) 2017; Diagnostics guidance [DG28]; available at https://www.nice.org.uk/guidance/dg28.
Join us in our vision.
#LetsFightCRC - At OLYMPUS, we believe that together we can push the limits of endoscopy, so that one day we could imagine a world without CRC.Join Now